Pulmonary Ionocytes Regulate CFTR-Mediated Chloride Transport in Human iPSC-Derived Epithelium
Year: 2026
Type: article
Abstract: RATIONALE: Pulmonary ionocytes, representing approximately 1% of airway epithelial cells, exhibit high CFTR expression and unique transcriptional markers, including FOXI1, ASCL3, and V-ATPase. Their exact role in human airway physiology is incompletely understood. OBJECTIVE: This study employs induced pluripotent stem cell (iPSC)-derived airway epithelial models (iPSC-airways) to elucidate the role of FOXI1 in pulmonary ionocyte differentiation and function. METHODS: CRISPR-Cas9 was used to generate FOXI1-knockout iPSCs, into which a doxycycline-inducible FOXI1-overexpression cassette was introduced. Edited and control lines were differentiated into airway epithelia to evaluate ionocyte formation, epithelial composition, and ion transport. Rescue studies assessed the effects of FOXI1 re-expression in a FOXI1-KO background, and the addition of inducible WT-CFTR ionocytes to F508del/F508del cystic fibrosis (CF) cultures on restoring chloride transport. MEASUREMENTS AND MAIN RESULTS: FOXI1 deletion abolishes ionocyte formation and alters airway epithelial composition, with increased mucus-secreting goblet cells and decreased ciliated cells. Functional assays confirmed ionocytes as key regulators of chloride homeostasis, with FOXI1-deficient airways displaying diminished ion transport. Induction of FOXI1-overexpression restored CFTR-mediated chloride transport. Introduction of WT ionocytes into CF airway models rescued chloride transport deficits, with no rescue observed in vehicle-treated controls lacking ionocyte induction. CONCLUSIONS: These findings highlight FOXI1's essential role in pulmonary ionocyte development, airway cell composition, and airway chloride transport. We present a fully manipulable, gene-edited iPSC-derived system that enables investigation of ionocyte biology and function within a human airway context, highlighting them as promising therapeutic targets for respiratory disorders.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: National Institutes of Health
Award: G9000054626
OpenAlex ID: W7226021733
